权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Centrosome instability as a mechanism to promote localized prostate cancer

中心体不稳定是促进局部前列腺癌的机制

基本信息

批准号：
10664978
负责人：
ANNE E CRESS
金额：
$ 58.57万
依托单位：
UNIVERSITY OF ARIZONA
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-22 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10664978
关键词：
3-Dimensional Address Aneuploidy Automobile Driving Basal Cell Biochemical Biogenesis Carcinoma in Situ Cells Centrosome Characteristics Chemicals Chromosomal Instability Chromosomes Clustered Regularly Interspaced Short Palindromic Repeats Copy Number Polymorphism Coupled Cultured Cells Cytoplasmic Organelle DNA Methylation DNA Sequence Alteration Data Disease Down-Regulation Early Diagnosis Early treatment Epithelial Cells Event Evolution Genomic Instability Goals Human Hypoxia In Situ Indolent Knowledge Lesion Malignant - descriptor Malignant Neoplasms Malignant neoplasm of prostate Mediating Microtubules Mission Mitotic Mitotic spindle Molecular Morphology Mus Mutation Nuclear Atypia Oncogenes Oncogenic Organ Organelles Organoids PLK1 gene Patients Physiological Probability Production Prostate Prostate Adenocarcinoma Prostatic Intraepithelial Neoplasias Prostatic Neoplasms Public Health Recurrence Reporting Research Role Series Structure System Testing Therapeutic Tissue Microarray Tumor Promotion Tumor Suppressor Genes United States National Institutes of Health Work Xenograft Model attenuation cancer diagnosis cancer therapy carcinogenesis chromothripsis genome integrity human tissue improved innovation insight methylation pattern molecular marker mouse model neoplastic cell novel precision oncology predictive marker prostate carcinogenesis treatment strategy tumor tumorigenesis tumorigenic

项目摘要

PROJECT SUMMARY/ABSTRACT There is a fundamental gap in our knowledge to explain the origin of prostate cancer (PCa). Unlike many cancers, PCa lacks signature mutations in key oncogenes and tumor-suppressor genes and, instead, displays large-scale genomic instability. We propose to study subcellular organelle instability as a mechanism that results in genomic instability in epithelial cells of the prostate gland. Specifically, we focus on centrosomes, tiny cytoplasmic organelles that dramatically influence genome integrity. Centrosomes can become subcellular pathognomonic structures when they are amplified, as is the case in many different cancers, causing mitotic errors, genomic instability and inducing tumorigenesis in mouse models. Likewise, centrosome loss causes mitotic errors and genomic instability identical to centrosome amplification, but has not been reported in cancer. We discovered recently that human prostate adenocarcinoma lack centrosomes, providing a novel mechanistic explanation for genomic instability in PCa. Our long-term goal is to discover the abnormal changes that underlie prostate tumorigenesis, malignancy and recurrence, and to improve PCa diagnosis and treatment strategies. The objective of this application is to determine the contribution of centrosome loss in driving genomic instability resulting in PCa and to determine the molecular mechanistic basis for centrosome disappearance. Drawn from our preliminary data, our central hypothesis is that hypoxia is a key physiologically-relevant determinant of centrosome loss in the prostate which, in turn, stimulates genomic instability and tumorigenesis. The rationale for the proposed research is to address the provocative question of how cancer-specific changes in subcellular pathognomonic structures (specifically, centrosome loss) transpire and contribute to carcinogenesis. This hypothesis will be tested in three specific aims: 1) Determine whether centrosome loss is triggered by hypoxia in prostate cells and tumors; 2) Determine whether centrosome loss drives genomic instability in normal prostate epithelial cells and promotes tumorigenesis; and 3) Determine if centrosome loss is characteristic of high-grade prostatic intraepithelial neoplasia (PIN, carcinoma in situ). The approach is innovative because it investigates a novel mechanism of subcellular organelle instability during prostate tumorigenesis: specifically, that hypoxia and centrosome biogenesis are mechanistically coupled as drivers of genomic instability in prostate tumor formation. The proposed research is significant because it tests a new concept that the loss of a critical subcellular organelle is responsible for PCa genomic instability, which is both a hallmark and agent of prostate tumor evolution. If we are correct, centrosome loss will be a tangible event early in the genesis of human prostate cancer, providing new early detection and treatment strategies.

项目总结/文摘

项目成果

期刊论文数量（1）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.

DOI：
10.3390/diagnostics12030676
发表时间：
2022-03-10
期刊：
Diagnostics (Basel, Switzerland)
影响因子：
0
作者：
Ryniawec JM;Coope MR;Loertscher E;Bageerathan V;de Oliveira Pessoa D;Warfel NA;Cress AE;Padi M;Rogers GC
通讯作者：
Rogers GC